Paul Tough discusses the rising rates of ADHD diagnoses, notably among American children, and the common treatment with stimulants like Ritalin and Adderall. Despite their popularity and perceived effectiveness, Tough highlights three decades of research questioning their safety and the validity of ADHD as a distinct brain disorder. This has led to a growing debate over the need for alternative treatments and a re-evaluation of how ADHD is understood and managed in pediatric care.
The increase in ADHD diagnoses raises important questions about its definition and the effectiveness of common stimulant treatments, prompting calls for alternative approaches.
Questions surrounding ADHD are primarily about its nature, with debates on whether it's a distinct disorder or a misunderstanding of childhood behavior.
Despite widespread use of medications like Ritalin and Adderall, three decades of research challenge their efficacy and safety, warranting a re-evaluation of ADHD’s treatment.
Historical protests against ADHD diagnosis and medication indicate a divide in society's understanding of childhood behavior and the medicalization of emotional health issues.
Collection
[
|
...
]